La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Piperazines »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pineal Gland < Piperazines < Piperidines  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000170 (2016) Annalisa Pinna ; Wai Kin D. Ko ; Giulia Costa ; Elisabetta Tronci ; Camino Fidalgo ; Nicola Simola ; Qin Li ; Mojgan Aghazadeh Tabrizi ; Erwan Bezard ; Manolo Carta ; Micaela MorelliAntidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000242 (2015) S. Abdelsayed ; N T Ha Duong ; C. Bureau ; P P Michel ; E C Hirsch ; J M El Hage Chahine ; N. SerradjiPiperazine derivatives as iron chelators: a potential application in neurobiology.
000370 (2015) Erwan Bezard ; Manolo CartaCould the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease?
000597 (2014) L. Gaboriau ; C. Victorri-Vigneau ; M. Gérardin ; G. Allain-Veyrac ; P. Jolliet-Evin ; M. Grall-BronnecAripiprazole: a new risk factor for pathological gambling? A report of 8 case reports.
000716 (2013) Erwan Bezard ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo CartaStudy of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
000878 (2012) O. Rascol ; J. Bronzova ; R A Hauser ; A E Lang ; C. Sampaio ; A. Theeuwes ; S V Van De WittePardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial.
000909 (2012) Benedicte Ballanger ; Helene Klinger ; Julien Eche ; Jérôme Lerond ; Anne-Evelyne Vallet ; Didier Le Bars ; Leon Tremblay ; Véronique Sgambato-Faure ; Emmanuel Broussolle ; Stéphane ThoboisRole of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.
000D05 (2008) M-A Crocq ; V. Camus ; B. Millet ; J. Gliskman ; J-M Azorin ; M-O Krebs ; F. Limosin ; J. Costentin ; J. Daléry[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
001100 (2003) Erwan Bézard ; Sandrine Ferry ; Ulrich Mach ; Holger Stark ; Ludovic Leriche ; Thomas Boraud ; Christian Gross ; Pierre SokoloffAttenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Piperazines" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Piperazines" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Piperazines
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024